Brief: Therapeuticsmd Announces First Quarter 2023 Financial Results
TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2023 FINANCIAL
RESULTS
* THERAPEUTICSMD INC - QTRLY NET LOSS FROM CONTINUING
OPERATIONS
$0.24 PER BASIC AND DILUTED COMMON SHARE
* THERAPEUTICSMD INC - CONTINUES TO WIND DOWN ITS FORMER
COMMERCIAL OPERATIONS AND TO FOCUS ON REDUCING COSTS
* THERAPEUTICSMD INC - QTRLY NET LOSS FROM DISCONTINUED
OPERATIONS
$0.13 PER BASIC AND DILUTED COMMON SHARE
Source text for Eikon: ID:nBw9V5b5Ra
Further company coverage: TXMD.O
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract